Stockwinners Market Radar for June 25, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
KMI | Hot Stocks18:55 EDT Kinder Morgan says 'very pleased' with Travis County District Court ruling - Kinder Morgan issued the following statement after the Travis County District Court dismissed all claims made against the Permian Highway Pipeline Project. "Kinder Morgan is very pleased with the ruling made by the Travis County District Court," said Tom Martin, president of Natural Gas Pipelines for KMI. "The court's finding validates the process established in Texas for the development of natural gas utility projects, as well as the steps we have taken to comply with that process. We will continue to engage all stakeholders as we work to complete PHP." The eminent domain process ensures that no single landowner can block critical infrastructure necessary to moving the energy needed to heat and cool homes, schools, businesses and public buildings in Texas -- while providing substantial local and state revenues.
|
MU... | Hot Stocks18:37 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: Micron (MU), up 8.6%... FedEx (FDX), up 0.6%. DOWN AFTER EARNINGS: AeroVironment (AVAV), down 9.7%. ALSO LOWER: Global Blood Therapeutics (GBT), down 3.7% after it announced a $200M common stock offering.
|
FDX | Hot Stocks18:03 EDT FedEx says U.S. government placing burden on carriers with regulations - Says lawsuit over regulations holding companies like FedEx accountable for illegal shipments without "any evidence." Says government is placing a burden on the common carrier with such regulations.
|
FDX | Hot Stocks18:01 EDT FedEx says Huawei packages 'only peripherally' involved in U.S. lawsuit - Says there's been "misreporting" on lawsuit against U.S. government. Says Huawei packages only peripherally involved in U.S. lawsuit. Says suit concerns not contraband but rather import and export controls as administered by the Department of Commerce. Says lawsuit about regulations on importing and exporting.
|
FDX AMZN | Hot Stocks17:58 EDT FedEx says loss of Amazon sales to be near term headwind
|
FDX | Hot Stocks17:56 EDT FedEx sees buyback level significantly lower in FY20 - Says has created new pricing programs for its Asian team to sell into Europe as well as Europe into Asia. Says stock buyback level expected to be significantly lower in FY20. Says management focused on improving near-term performance.
|
FDX | Hot Stocks17:51 EDT FedEx says has made no pricing changes - Says business realignment activities are expected to benefit FY20 by roughly $240M. Sees achieving cost savings goal with less severance than expected.
|
FDX | Hot Stocks17:46 EDT FedEx says international commercial team still poised for growth - Says TNT Express salesforce now 98% integrated. Sees services continuing to underpin global GDP growth. Says deceleration in Chinese economy has also affected export performance in other Asian markets. Says outlook for European economy remains slow, partially due to uncertainty around Brexit. Says tariffs "counterproductive" to growth efforts. Says international commercial team still poised for growth despite macroeconomic headwinds.
|
FDX | Hot Stocks17:43 EDT FedEx says global trade picture 'less than ideal' - Says "all-in" on e-commerce. Sees FedEx Ground becoming the biggest low-cost delivery provider in the future. Sees rise of short haul from retail stores to homes. Says global trade picture "less than ideal." Says implementing initiatives to improve cost to serve in e-commerce.
|
FDX | Hot Stocks17:38 EDT FedEx calls FY20 a 'transition year' - Says FY20 a "transition year" for the company. Says aims to capitalize on e-commerce growth. Sees parcel market in U.S. doubling in size by 2026.
|
FDX | Hot Stocks17:37 EDT FedEx says intends to substantially grow e-commerce business - Sees FedEx Freight will increase earnings and margins going forward. Sees FedEx Ground increasing margins in 2020. Says global trade disputes create uncertainty for Express business. Says intends to substantially grow e-commerce business. Says short haul package delivery will become increasingly important going forward. Comments taken from Q4 earnings conference call.
|
CNX | Hot Stocks17:36 EDT CNX Resources director Bernard Lanigan purchases 36,200 shares of company stock - CNX Resources director Bernard Lanigan disclosed in a filing that he had purchased 36,200 shares of company stock at $6.91 per share on June 25. The total transaction value of the purchase was $250,124.
|
FTI | Hot Stocks17:32 EDT TechnipFMC confirms settlement with U.S., Brazilian enforcement authorities - TechnipFMC has agreed to resolutions with the U.S. Department of Justice, the U.S. SEC Staff and the Brazilian authorities, the Comptroller General of Brazil, and the Attorney General of Brazil to resolve anti-corruption investigations in Brazil and relating to the intermediary, Unaoil. The company has agreed to pay a total of $301.3M to these authorities to resolve investigations into conduct dating back over a decade ago. TechnipFMC fully cooperated with these authorities, and this is the first simultaneous resolution to include all U.S. and Brazilian authorities. TechnipFMC will not be required to have a monitor and will, instead, provide reports on its anti-corruption program to the Brazilian and U.S. authorities for two and three years, respectively. As part of this resolution, TechnipFMC entered into a three-year Deferred Prosecution Agreement with the DOJ related to charges of conspiracy to violate the Foreign Corrupt Practices Act related to conduct in Brazil and with Unaoil. In addition, Technip USA, Inc., a U.S. subsidiary, pled guilty to one count of conspiracy to violate the FCPA related to conduct in Brazil. The company will also provide the DOJ reports on its anti-corruption program during the term of the DPA. In Brazil, TechnipFMC subsidiaries Technip Brasil - Engenharia, Instalacoes E Apoio Maritimo Ltda. and Flexibras Tubos Flexiveis Ltda. entered into leniency agreements with both the MPF and the CGU/AGU related to conduct in Brazil dating back over a decade ago. The company has committed, as part of those agreements, to make certain enhancements to their compliance programs in Brazil during a two-year self-reporting period, which aligns with its commitment to cooperation and transparency with the compliance community in Brazil and globally. Additionally, TechnipFMC has reached an agreement in principle with the SEC Staff, subject to final SEC approval. As previously disclosed, TechnipFMC has also been cooperating with an investigation by the French Parquet National Financier related to historical projects in Equatorial Guinea and Ghana. To date, this investigation has not reached resolution. TechnipFMC remains committed to finding a resolution with the PNF and will maintain a $70M provision related to this investigation.
|
FTI | Hot Stocks17:15 EDT TechnipFMC, subsidiary to pay $296M to resolve foreign bribery charges - TechnipFMC and its wholly-owned U.S. subsidiary, Technip USA, have agreed to pay a combined total criminal fine of more than $296M to resolve foreign bribery charges with authorities in the United States and Brazil. TFMC is the product of a 2017 merger between two predecessor companies, Technip S.A. and FMC Technologies. The charges arose out of two independent bribery schemes: a scheme by Technip to pay bribes to Brazilian officials and a scheme by FMC to pay bribes to officials in Iraq. Technip USA and Technip's former consultant pleaded guilty in connection with the resolution. In 2010, Technip entered into a $240M resolution with the Department over bribes paid in Nigeria. Reference Link
|
ORRF | Hot Stocks17:11 EDT Orrstown Financial names Thomas Brugger EVP and CFO - Orrstown Financial Services announced that Thomas R. Brugger will join the company and the Bank as Executive Vice President and Chief Financial Officer effective July 15. Mr. Brugger will be responsible for the Company's financial plans, policies, and financial compliance. Brugger graduated with a degree in accounting from the Pennsylvania State University and has more than 19 years of banking experience. Most recently, Mr. Brugger served as the Chief Financial Officer of Sun National Bank and, prior to his approximately six year tenure at Sun National, served as CFO of Customers Bank, following 15 years as EVP/Corporate Treasurer of Sovereign Bank. Thomas R. Quinn, Jr., President & CEO, commented, "We are pleased to welcome Tom to the organization. His broad banking and financial experience at diverse and complex organizations will be invaluable as we continue to execute our strategic growth plans."
|
MU | Hot Stocks17:07 EDT Micron says it has mitigated 90% of China tariff impact - Says U.S. tariffs on goods from China had less than a 30 basis point impact on gross margin. Says still expects FY19 capital expenditures of $9B. Says Huawei ban will negatively impact Q4 revenue.
|
AITB | Hot Stocks17:05 EDT AIT Therapeutics plans to file PMA submission with FDA for PPHN with AirNOvent - On track to file a premarket approval submission with the FDA in the third quarter of calendar 2019 for the treatment of persistent pulmonary hypertension of the newborn with the AirNOvent.
|
MU | Hot Stocks16:48 EDT Micron says it can resume shipping a certain subset of products to Huawei - Says expects healthy year-over-year cost declines in both NAND and DRAM in FY19. Says determined the company can lawfully resume shipping a certain subset of products to Huawei. Says continuing with 5% idling of DRAM wafer starts. Says reducing NAND wafer starts by 10%. Says expects FY20 capital expenditures to be meaningfully lower than FY19. Comments taken from Q3 earnings conference call.
|
AVAV | Hot Stocks16:42 EDT AeroVironment down 9.5% to $55.50 after Q4 results, FY20 guidance - The midpoint of the company's FY20 profit guidance fell short of analysts' estimates.
|
CRTO | Hot Stocks16:39 EDT Criteo COO Mollie Spilman to leave company - Criteo S.A. announced that COO Mollie Spilman has decided to leave the company to pursue a new career opportunity. She will continue with the company through the end ofQ2 and depart on July 5. With Spilman's departure, CEO JB Rudelle will directly manage the sales and operations teams.
|
KHC | Hot Stocks16:37 EDT Kraft Heinz accelerates new CEO start date to June 25 - In a regulatory filing, the company said, "As previously announced on April 17, 2019, The Kraft Heinz Company's Board of Directors approved the appointment of Miguel Patricio as Chief Executive Officer of Kraft Heinz. On June 20, 2019, Kraft Heinz decided to accelerate Mr. Patricio's start date to June 25, 2019 due to the upcoming July 4th holiday in the United States. As part of various organizational changes approved by the Board, in addition to his role as the global CEO, Mr. Patricio will assume the role of U.S. Zone President on an interim basis, and Paulo Basilio, who currently serves as U.S. Zone President of Kraft Heinz, will assume the new role of Chief Business Planning and Development Officer, effective July 1, 2019. Also, effective July 1, 2019, Rafael Oliveira, who currently serves as the Zone President of Europe, Middle East and Africa segment of Kraft Heinz, will assume the new role of International Zone President of Kraft Heinz."
|
GBCI | Hot Stocks16:34 EDT Glacier Bancorp raises dividend to 27c from 26c - Glacier Bancorp declared a quarterly dividend of 27c per share. The Company has declared 137 consecutive quarterly dividends and has increased the dividend 44 times. The dividend is payable on July 18 to owners of record on July 9.
|
DRRX | Hot Stocks16:31 EDT Durect receives approval to transfer to Nasdaq Capital Market - Durect Corporation announced that it received approval from the Listing Qualifications Department of The Nasdaq Stock Market to transfer the listing of the company's common stock from the Nasdaq Global Market to the Nasdaq Capital Market, effective June 27. The company has also been granted an additional 180-day grace period, or until December 23, to regain compliance with Nasdaq's minimum bid price requirement. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq's corporate governance requirements. The company's common stock will continue to trade under the symbol "DRRX."
|
COWN | Hot Stocks16:31 EDT Cowen Group names CEO Jeffrey Solomon as chairman of the board - Cowen is pleased to announce that, following the Company's 2019 annual meeting, Chief Executive Officer Jeffrey M. Solomon has been named Chairman of its Board of Directors. Outgoing Chairman Jerome S. Markowitz is now serving as Lead Independent Director. "Since becoming CEO in December 2017, Jeff has demonstrated the leadership to take Cowen to higher levels," said Mr. Markowitz. "As an organization dedicated to enabling clients to outperform, Jeff's drive, innovative thinking and vision make him the right person for the chairmanship. The Board looks forward to working with him in his newly expanded leadership role." Commenting on his appointment, Mr. Solomon said, "I am honored to take on this important role and am grateful for the Board's confidence in me. My fellow directors and I thank Jerry for his stewardship as Chairman over the past year, and I am especially grateful for his mentorship and guidance. I look forward to working with the Board and our talented colleagues to position Cowen for our next phase of growth."
|
SNX | Hot Stocks16:27 EDT Synnex up 4% to $95.98 after Q2 results beat estimates - The midpoint of the company's Q3 guidance also topped estimates.
|
CRCM | Hot Stocks16:25 EDT Care.com CFO Michael Echenberg to resign, effective August 30 - In a regulatory filing, Care.com disclosed that on June 21, Michael Echenberg tendered his resignation as the Executive Vice President and CFO of Care.com, such resignation to be effective on August 30. The company expects that Michael Goss, the company's Vice President of Finance, will be appointed acting CFO of the company upon the effectiveness of Echenberg's resignation. Echenberg will assist in the transition of the CFO role until his departure from the company.
|
TPL | Hot Stocks16:25 EDT Investor group responds to Texas Pacific Land Trust proposal - SoftVest, Horizon Kinetics and ART-FGT Family Partners, the Investor Group which collectively beneficially owns over 25% of the outstanding shares of Texas Pacific Land Trust, announced that Murray Stahl, Chairman of Horizon Kinetics, has sent a letter to David Barry and John Norris in response to the Trust's formation of a "Conversion Exploration Committee" to evaluate a conversion of the Trust into a C-corporation. Letter began "Thank you for your proposal. Some months ago, when we began the process to elect Eric Oliver as the Trust's third trustee, it never occurred to us that on the eve of the election you would attempt to cancel the shareholders' vote and sue us. In doing so, you made the choice to move the contest to the courtroom, a forum that you selected, and the nature of which requires some time to make the appropriate response. Yet, now that we are engaged with you in the legal process, you wish to shift to the mechanism of a Committee to explore the topic of corporate governance." At the end letter included "We propose, then, the following: send a list of shareholders to all of the other shareholders, so that they may engage with one another on this important topic and other matters critical to the future of TPL. This will allow them to properly prepare for any future votes and interaction with the Trustees. For there is nothing secret about corporate governance; it is based on transparency, and we ourselves have no monopoly on the topic or its practice."
|
BIG | Hot Stocks16:21 EDT Big Lots reaffirms Q2 and FY19 outlook - In connection with the appointment of Jonathan Ramsden has been appointed Executive Vice President, Chief Financial and Administrative Officer, Big Lots reaffirmed its financial forecast for the Q2 and FY19, as previously disclosed on May 31.
|
CNO | Hot Stocks16:19 EDT CNO Financial upgraded by S&P and Fitch - Two ratings agencies, S&P and Fitch recently upgraded the credit ratings of CNO Financial Group. With these two upgrades, CNO Financial is now rated investment grade by all four leading ratings agencies - A.M. Best, Moody's, Fitch and S&P. On June 21, S&P Global Ratings raised CNO's senior unsecured debt rating to 'BBB-' from 'BB+' and the financial strength rating of the company's operating subsidiaries to 'A-' from 'BBB+'. The rating outlook is stable. On June 14, Fitch Ratings upgraded CNO's senior unsecured debt rating to 'BBB-' from 'BB+' and the financial strength rating of the company's operating subsidiaries to 'A-' from 'BBB+'. The rating outlook is also stable. On October 4, 2018, Moody's Investors Service upgraded CNO's senior unsecured debt rating to 'Baa3' from 'Ba1' and the financial strength rating of the company's operating subsidiaries to 'A3' from 'Baa1'. The rating outlook is also stable.
|
BIG ANF | Hot Stocks16:19 EDT Big Lots appoints Jonathan Ramsden as Chief Financial and Administrative Office - Big Lots announced that Jonathan Ramsden has been appointed Executive Vice President, Chief Financial and Administrative Officer, effective August 5. Ramsden will succeed Timothy A. Johnson, who will transition away from his roles effective August 5, to pursue other opportunities in the for-profit and not-for-profit arenas. Johnson has agreed to continue in an advisory role through Labor Day to provide the opportunity for a smooth transition for the business. Ramsden brings to Big Lots more than 20 years of experience in senior executive roles with U.S. public companies in the retail and marketing services industries. Ramsden spent over seven years with Abercrombie & Fitch (ANF), joining as CFO in 2008 and later serving as the company's COO, where his responsibilities included finance, strategy, technology, legal, supply chain, real estate and e-commerce, and as Interim Principal Executive Officer and as a member of the Office of the Chairman following the departure of the former CEO. In connection with today's announcement, Big Lots reaffirmed its financial forecast for the Q2 and FY19, as previously disclosed on May 31.
|
SNX | Hot Stocks16:17 EDT Synnex CEO says 'both business segments exceeded expectations' in Q2 - "We delivered strong results in our second quarter as both of our business segments exceeded expectations and set quarterly records," said Dennis Polk, SYNNEX President and CEO. "Our Concentrix business continued its momentum post the Convergys acquisition by delivering solid results, while executing ahead of schedule on our integration plan."
|
PGRE | Hot Stocks16:16 EDT Paramount Group to acquire 55 Second Street for about $408M - Paramount Group announced that it has entered into an agreement to acquire 55 Second Street, a 387,000 square foot trophy office building located in San Francisco's South Financial District, for approximately $408M or $1,054 per square foot. The transaction, which is subject to customary closing conditions, is expected to close in the third quarter of 2019. In connection with the transaction, the company expects to bring in a joint venture partner prior to closing.
|
APLE | Hot Stocks16:15 EDT Apple Hospitality REIT names Rachael Rothman CFO - Apple Hospitality REIT announced the appointment of Rachael Rothman to the position of Executive Vice President and Chief Financial Officer for the company, effective July 1, 2019. Rothman will succeed Bryan Peery as Executive Vice President and Chief Financial Officer. As previously announced, Peery plans to retire from the company in the first quarter of 2020. Peery will continue as Executive Vice President and, effective July 1, 2019, will become Chief Accounting Officer for the company.
|
MU | Hot Stocks16:12 EDT Micron jumps 6% after reporting Q3 results - Shares of the company are up 5.92% or $1.94 per share to $34.62 per share in after-hours trading.
|
MU | Hot Stocks16:10 EDT Micron plans reduction in CapEx in FY20 - "Micron's improved competitive position and strong execution helped us deliver solid results despite a challenging environment," said Micron Technology President and CEO Sanjay Mehrotra. "While we are seeing early signs of demand improvement, we plan to reduce our capital expenditures in fiscal 2020 to help improve industry supply-demand balance."
|
JAX | Hot Stocks16:09 EDT Ancora Advisors urges J. Alexander's Board to review strategic alternatives - Ancora Advisors, which beneficially owns approximately 8.76% of the outstanding shares of J. Alexander's Holdings, making it one of the company's largest shareholders, announced that the final results of J. Alexander's 2019 annual meeting confirm that shareholders have clearly and convincingly endorsed Ancora's case for change. According to the final voting results, which have been certified by the independent inspector of election, at J. Alexander's 2019 annual meeting, approximately (1) 53.2% and 60.2% of the outstanding shares of the company withheld their votes from management's incumbent nominees, Timothy Janszen and Ronald Maggard, respectively, (2) 61.7% and 69.7% of the votes cast in the election of directors were withheld from Messrs. Janszen and Maggard, respectively, and (3) 77.7% and 87.8% of the votes cast in the election of directors (excluding shares held by insiders and affiliates of the company) were withheld from Messrs. Janszen and Maggard, respectively. Frederick DiSanto, Chairman and CEOof Ancora, commented: "Through the decisive vote at the 2019 annual meeting, we believe shareholders have sent a clear directive to the board that the status quo is unacceptable and that the Company should immediately explore strategic alternatives. Recent transactions in the restaurant space, particularly the sale of Del Frisco's Restaurant Group which was announced earlier this week at an attractive deal multiple, only serve to reinforce our belief that the optimal outcome for J. Alexander's shareholders is a sale of the Company. J. Alexander's shares currently trade at a meaningful discount to private market value, and this leadership team lacks a cogent plan for closing that discount and driving value for shareholders. Unlike at the annual meeting, at which not a single one of the independent directors was present in person, the J. Alexander's board now needs to show up for shareholders and take a hands-on approach to a strategic process that culminates in the sale of the company to the highest bidder."
|
EYES | Hot Stocks16:09 EDT Second Sight reports 'positive' results from Orion feasibility study - Second Sight Medical Products announced that 12-month results from the company's Early Feasibility Study of the Orion Visual Cortical Prosthesis System will be presented today at the World Society for Stereotactic and Functional Neurosurgery Annual Meeting in New York City. On both the primary and secondary outcome measures, latest results at 12 months have been positive. The study's principal investigators, Nader Pouratian, MD, Ph.D. of Ronald Reagan UCLA Medical Center, and Daniel Yoshor, MD of Baylor College of Medicine, are presenting the topline data. Orion is a breakthrough technology intended to provide useful artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. Orion converts images captured by a miniature video camera mounted on glasses into a series of small electrical pulses transmitted wirelessly to electrodes implanted directly on the visual cortex of the individual subject's brain. "We are pleased with the continued favorable progress being made in the Orion Early Feasibility Study among the six study participants. The first four subjects have now reached 12 months post-implant, and participants appear to be making steady improvements in their ability to perform everyday tasks and successfully meet the study's functional vision endpoint goals. It is also encouraging to see that when compared with similar Argus II feasibility study results at the 12-month mark, the Orion study participants are doing as well as or better than Argus II participants in most measurements, such as the Functional Low-Vision Observer Rated Assessment (FLORA). We look forward to continued collaboration with our study investigators and to advancing our Orion technology platform," said Will McGuire, President and Chief Executive Officer of Second Sight.
|
FDX | Hot Stocks16:08 EDT FedEx CEO calls 2019 'a year of both challenge and change' - "Fiscal 2019 was a year of both challenge and change for FedEx," said Frederick W. Smith, FedEx Corp. chairman and CEO. "We are proud of our team members, who are responding with positive actions and innovative solutions that will make FedEx even stronger and more successful in the future. FedEx enters fiscal 2020 with a sharp focus on extending our lead as the premier global transportation and logistics company and on making the necessary investments today to capture the significant market opportunities we see for the future. These actions include enhancing FedEx Ground capabilities, speed and efficiency; improving FedEx Express hub automation; modernizing our FedEx Express air fleet; integrating TNT Express; and reducing unit costs and increasing productivity."
|
PDLI | Hot Stocks16:06 EDT PDL BioPharma announces resignation of CFO Peter Garcia - PDL BioPharma announced the resignation of CFO, Peter Garcia, who will be leaving the Company effective August 15. He will continue in his role through the filing of the Company's Q2 10-Q in August and is committed to ensure a smooth transition of duties. The Company is retaining an executive search firm to lead the search for his replacement.
|
SSTK | Hot Stocks16:04 EDT Shutterstock announces departure of CFO and Co-COO Steven Berns - Shutterstock announced that Co-COO and CFO Steven Berns will depart from his roles at Shutterstock to pursue other opportunities, effective immediately. Berns' departure is not due to a dispute or any matter relating to the Company's accounting and financial policies and operations. The Company's Chief Accounting Officer, Steve Ciardiello has been appointed to the role of interim CFO until a successor has been named. Ciardiello will also continue in his existing role as Chief Accounting Officer. Shutterstock also announced today that Stan Pavlovsky, who had been serving as Co-COO and Head of Strategic Operations, has been named President and COO. In his expanded role as President and COO, Stan will now oversee Shutterstock's Sales and Operations team, in addition to continuing to oversee the Company's Product, Marketing, and Technology teams.
|
COTY | Hot Stocks16:00 EDT Coty names Sophie Hanrot chief HR officer - Coty announced the appointment of Sophie Hanrot as Chief Human Resources Officer, effective July 1, 2019. Sophie will serve as a member of the Coty Executive Committee and report to Coty's CEO Pierre Laubies. Sophie succeeds Sebastien Froidefond who will be leaving Coty for personal reasons.
|
SAFM | Hot Stocks15:37 EDT Sanderson Farms comments on legal proceedings, says claims 'without merit' - Sanderson Farms issued the following statement regarding certain ongoing legal proceedings: "The United States Department of Justice filed a motion on Friday, June 21, 2019, in In re Broiler Chicken Antitrust Litigation stating that it is conducting a criminal investigation regarding the broiler industry. The Company has not been subpoenaed in connection with the Department of Justice investigation. The Company continues to believe the civil plaintiffs' claims as to Sanderson Farms are wholly without merit, and we are committed to defending the case vigorously."
|
SAFM | Hot Stocks15:37 EDT Sanderson Farms sees civil plaintiffs' claims as 'wholly without merit'
|
SAFM | Hot Stocks15:36 EDT Sanderson Farms says has not been subpoenaed in connection with DOJ probe
|
W | Hot Stocks15:09 EDT Wayfair slides as workers plan walkout over furniture sale to migrant camps - Shares of Wayfair (W) are under pressure on Tuesday after workers reportedly plan walkout over furniture sales to migrant camps. This comes after employees at the company learned last week that a $200,000 order of bedroom furniture had been placed by BCFS, a government contractor that has been operating camps at the border, according to a media report. WORKERS PLAN WALKOUT: Workers at Wayfair said that they would stage a walkout at the online housewares giant's Back Bay offices Wednesday to protest the company's decision to sell furniture to operators of facilities for migrant children detained at the southern U.S. border, Janelle Nanos of the Boston Globe reported. Employees at the company learned last week that a $200,000 order of bedroom furniture had been placed by BCFS, a government contractor that has been operating camps at the border, Nanos said, citing a Wayfair employee. "We were disheartened and concerned about Wayfair's business" with BCFS, the employee said. "Over the last two days it has come to our attention that Wayfair has again engaged in B2B sales with BCFS, a non-profit government contractor managing camps for migrants at our Southern border," a group of 50 employees said in a letter sent to Wayfair's executive leadership. "This particular order, for over $200,000 worth of bedroom furniture, is destined for Carrizo Springs, Texas, to a facility that will be outfitted to detain up to 3,000 migrant children seeking legal asylum in the United States. The practice of detaining children and adults at our Southern border has been condemned since its inception but since the acceleration of the practice in 2018, and the increase in death and injury that has come with that acceleration, we have seen more vocal condemnation of the practice. We, the undersigned, are writing to you from a place of concern and anger about the atrocities being committed at our Southern border." In a tweet, House Representative Alexandria Ocasio-Cortez commented on the planned walkout saying that, "Wayfair workers couldn't stomach they were making beds to cage children. They asked the company to stop. CEO said no. Tomorrow, they're walking out. This is what solidarity looks like - a reminder that everyday people have real power, as long as we're brave enough to use it." PRICE ACTION: In afternoon trading, shares of Wayfair have dropped almost 5% to $145.39.
|
FB | Hot Stocks15:03 EDT Facebook offering more transparency for social, political ads in more countries - Facebook product manager Sarah Schiff, said in part: "We believe that transparency leads to increased accountability and responsibility over time - not just for Facebook but advertisers as well. It's why we continue to introduce tools that allow elected officials, those seeking office, and organizations aiming to influence public opinion to show more information about the ads they run and who's behind them. At the same time, we're continuing our work to combat foreign interference in elections worldwide. Starting today, we are rolling out our transparency tools globally for advertisers wanting to place ads about social issues, elections or politics. For a full list of countries and territories where these tools are now available, visit our Help Center...Beginning today, we will systematically detect and review ads in Ukraine and Canada through a combination of automated and human review. In Singapore and Argentina, we will begin enforcement within the next few months. We also plan to roll out the Ad Library Report in both of those countries after enforcement is in place..Elections are happening all over the world and some happen with very little notice. We are committed to requiring authorizations and disclaimers for social issue, electoral or political ads in more places." Reference Link
|
BAESY | Hot Stocks14:38 EDT BAE Systems announces award of $67M contract modification from Marines - BAE Systems announced along with teammate Iveco Defence Vehicles that they have been awarded a $67M contract modification by the U.S. Marine Corps to develop new variants for the Amphibious Combat Vehicle Family of Vehicles program for enhancing battlefield situational awareness and firepower.
|
NVCN | Hot Stocks14:31 EDT Neovasc says compliance regained with Nasdaq minimum market value rule - Neovasc announced that it has received written notification from The Nasdaq Stock Market notifying the company that it has regained compliance with the minimum market value requirement set forth in the rules for continued listing on the Nasdaq Capital Market. The company must still regain compliance with the minimum bid price requirement before July 15, Neovasc noted.
|
SPY SPX | Hot Stocks14:31 EDT Fed Chair Powell reemphasized its independence from political pressure - At the Council on Foreign Relations, Fed Chair Jerome Powell said :"The Fed is insulated from short-term political pressures - what is often referred to as our 'independence. During our public review, we are seeking perspectives from people across the nation, and we are doing so through open public meetings live-streamed on the internet. Let me share some of the thinking behind this review, which is the first of its nature we have undertaken. The Fed is insulated from short-term political pressures-what is often referred to as our "independence." Congress chose to insulate the Fed this way because it had seen the damage that often arises when policy bends to short-term political interests. Central banks in major democracies around the world have similar independence." Reference Link
|
AMZN | Hot Stocks14:04 EDT Amazon teams with Seattle Public Schools to bring computer science and robotics - Amazon and Seattle Public Schools today announced a new partnership to bring computer science and robotics to up to 30 Title 1 Seattle Public Schools as part of the Amazon Future Engineer program. Amazon is providing each of the schools with an Amazon Future Engineer Robotics grant to inspire the next generation of computer scientists, with a focus on students from underrepresented and underserved communities. Each of the schools will receive support to launch FIRST robotics teams, including teacher professional development to learn about robotics, support from Amazon to expand access to computer science education in their school, and a private tour of an Amazon robotics fulfillment center in Kent, Washington.
|
TDG | Hot Stocks13:25 EDT DoD: TransDigm 'negotiating excessive profits' on contracts for spare parts - The Department of Defense Inspector General said in a statement that it found that TransDigm and its subsidiaries are "engaging in a pervasive strategy of negotiating excessive profits on contracts with the Department for spare parts." It said the report found that TransDigm is the only manufacturer of the majority of the spare parts the IG included in its review, putting TransDigm "either in a sole source position or in a situation where it had the opportunity to set the market prices even for competitively awarded parts." Kim Herrington, Acting Principal Director, Defense Pricing and Contracting, said that "for all procurement actions not yet awarded, unless the prices agreed upon are based on adequate price competition or are set by law or regulation, contracting officers are directed to require the submission of uncertified cost or pricing data to support prices proposed by TransDigm." Reference Link
|
ORCL | Hot Stocks13:03 EDT Oracle announces 'simplified' analytics product offering - Oracle said in a press release that it "unveiled a new, customer-centric vision" for Oracle Analytics at the company's Analytics Summit. T.K. Anand, senior vice president, AI, Data Analytics and Cloud, Oracle, said, "Today, we are announcing a new vision, product experience, and commitment to customer success that will enable us to collaborate with our entire ecosystem and deliver a new era of enterprise analytics." The company said highlights include a simplified product offering and "clarity of direction by rationalizing 18+ products down to a single brand"; the "industry's leading application analytics built on the Autonomous Data Warehouse and powered by Oracle Analytics Cloud; and "affordable per user pricing for departmental business users plus per-CPU pricing for broad enterprise scale."
|
GOOG GOOGL | Hot Stocks12:33 EDT Senator Markey urges FTC to require added children's safeguards at YouTube - Senator Edward J. Marke, a member of the Commerce, Science, and Transportation Committee, sent a letter to the Federal Trade Commission expressing concern that YouTube has violated the Children's Online Privacy Protection Act. Following media reports that the FTC is investigating YouTube for its collection of children's data, Senator Markey is urging the Commission to include a series of new privacy safeguards that YouTube should implement as part of any potential consent decree stemming from a Commission investigation. These safeguards include deleting all data under Google's control collected from children under 13, instituting mechanisms to identify on an ongoing basis any YouTube users under 13, and prohibiting Google from launching any new child-directed product or service in the future until the product or service has been reviewed and approved by an independent panel of experts, including child development and privacy experts, to be appointed by the FTC. Senator Markey also called on the FTC to require Google to sponsor a consumer education campaign warning parents that no one under the age of 13 should use YouTube, as well as to establish a fund to produce and amplify noncommercial, quality content for children. "Companies of all types have strong business incentives to gather and monetize information about children," writes Senator Markey."Personal information about a child can be leveraged to hook consumers for years to come, so it is incumbent upon the FTC to enforce federal law and act as a check against the ever increasing appetite for children's data." Reference Link
|
KO | Hot Stocks12:30 EDT American Dream announces 10-year partnership with Coca-Cola - American Dream announced a 10-year partnership with The Coca-Cola Company and its local bottling partner, Liberty Coca-Cola Beverages. "This multimillion-dollar program is an alliance between two global brands that will fully-integrate Coca-Cola's portfolio through dining, fashion, music, art and entertainment. American Dream is scheduled to open in Fall 2019 in East Rutherford, New Jersey, and it will include more than 450 retail, food and specialty shops, along with more than 15 entertainment offerings. The complex will be three million square feet and projects 40 million visitors annually," the development group for the project announced. Coca-Cola's integration throughout American Dream will feature bespoke events, an in-line social media storefront, Coca-Cola green rooms for VIPs and "Coca-Cola Eats," a branded dining destination that will seat approximately 800 guests.
|
MMTOF | Hot Stocks12:19 EDT Mitsubishi Motors North America relocating U.S. headquarters to Tennessee - Mitsubishi Motors North America announced that it will relocate its headquarters from Cypress, California, to Franklin, Tennessee, a suburb of Nashville. Mitsubishi said in a statement that the move is part of an ongoing plan to "reinvent every aspect of Mitsubishi Motors in the U.S., from corporate leadership to dealer partners to every touchpoint in a customer's relationship with their vehicle, and will sharpen the company's focus on future growth and innovation." This move will begin in August, and be completed by the end of 2019. There are nearly 200 people working in MMNA's Cypress office. All corporate departments will be relocating, including sales, marketing, IT, human resources, communications, parts and service, product planning, dealer operations, finance and legal. Additionally, 25 employees representing the company's Western Region operations will move to new offices elsewhere in Orange County, California. No other Mitsubishi Motors facilities in the U.S. are affected, including Mitsubishi Research and Development North America's R&D operations in Ann Arbor, Michigan and MRDA government relations operations in Washington, D.C.
|
DLTR | Hot Stocks12:08 EDT Dollar Tree director Thomas Saunders sells over $1.6M in company shares - Dollar Tree director Thomas Saunders disclosed in a filing that he had sold 14,530 shares of company stock at an average price of $111.85 per share between June 21 and June 24. The total transaction value of the sale was $1,625,166.
|
RGS | Hot Stocks12:00 EDT Regis falls -6.4% - Regis is down -6.4%, or -$1.14 to $16.62.
|
EQT | Hot Stocks12:00 EDT EQT Corporation falls -6.6% - EQT Corporation is down -6.6%, or -$1.01 to $14.37.
|
ABBV | Hot Stocks12:00 EDT AbbVie falls -15.1% - AbbVie is down -15.1%, or -$11.81 to $66.64.
|
USNA | Hot Stocks12:00 EDT Usana rises 8.6% - Usana is up 8.6%, or $6.25 to $78.59.
|
PYX | Hot Stocks12:00 EDT Pyxus rises 23.0% - Pyxus is up 23.0%, or $3.09 to $16.52.
|
AGN | Hot Stocks12:00 EDT Allergan rises 26.6% - Allergan is up 26.6%, or $34.43 to $164.00.
|
LEN | Hot Stocks11:34 EDT Lennar remains confident in reaching FY19 home delivery target of 50,000 homes - Expects margins to increase in Q3 and Q4. Management said 75% of Texas land will be for entry-level communities. Management said more entry-level sales will drive down average prices. Management said land entitlement is taking longer and driving costs higher. Management sees FY19 deliveries of 50,500-51,000 homes with an average price of $400,000. Stuart Miller, Executive Chairman of Lennar, said the housing market is improving.
|
AJG | Hot Stocks10:01 EDT Arthur J. Gallagher to acquire minority stake in Renomia a.s. - Arthur J. Gallagher & Co. announced that it has signed an agreement to purchase a minority stake in Prague-based Renomia a.s. The deal is subject to regulatory approval and is expected to close in the third quarter. Renomia is the largest independent broker based in the Central and Eastern European region, with more than 1,500 colleagues serving clients under the Renomia brand, via its extensive franchise partner network.
|
PPDF | Hot Stocks10:00 EDT PPDAI Group falls -7.4% - PPDAI Group is down -7.4%, or -32c to $4.00.
|
FTSI | Hot Stocks10:00 EDT FTS International falls -7.5% - FTS International is down -7.5%, or -43c to $5.33.
|
ABBV | Hot Stocks10:00 EDT AbbVie falls -14.8% - AbbVie is down -14.8%, or -$11.59 to $66.86.
|
USNA | Hot Stocks10:00 EDT Usana rises 9.4% - Usana is up 9.4%, or $6.80 to $79.14.
|
AGN | Hot Stocks10:00 EDT Allergan rises 27.4% - Allergan is up 27.4%, or $35.48 to $165.05.
|
PYX | Hot Stocks10:00 EDT Pyxus rises 27.8% - Pyxus is up 27.8%, or $3.73 to $17.16.
|
IHG SCHYY | Hot Stocks09:49 EDT InterContinental, Sands China extend partnership - InterContinental (IHG) and Sands China (SCHYY) announced that The Venetian Macao and The Parisian Macao will become InterContinental Alliance Resorts beginning today. In addition, The Londoner Hotel in Macao will join the alliance when it opens in 2020 following the renovation of the current Holiday Inn Macao Cotai Central. IHG and The Venetian Resort Las Vegas also announced the long-term extension of their alliance. The partnership extends through to 2027 at all five properties, the companies said.
|
GTES | Hot Stocks09:47 EDT Gates Industrial rises 19.1% - Gates Industrial is up 19.1%, or $2.06 to $12.86.
|
PYX | Hot Stocks09:47 EDT Pyxus rises 26.5% - Pyxus is up 26.5%, or $3.56 to $16.99.
|
AGN | Hot Stocks09:47 EDT Allergan rises 29.4% - Allergan is up 29.4%, or $38.05 to $167.62.
|
ABBV AGN | Hot Stocks09:31 EDT AbbVie says looked at Allergan deal for over a year - Says: Highly unlikely to see a biosimilar to Botox... Plans to invest heavily in Botox business... Comfortable with opioid litigation risk... Has very large early to mid-stage pipeline of drugs... Will continue to look for innovative products... Humira paying for replacement products... Does not anticipate any issues with FTC process... Expects strong, growing dividend... Breakup fee is 1% on their side, 2% on our side... Merger has been a very cooperative process... Does not view transaction as having high level of integration risk... 50% of synergies to come from R&D... Has built in modest assumptions on Allergan's pipeline... The transaction is not highly dependent on pipeline. Comments from AbbVie, Allergan acquisition conference call.
|
PRPO | Hot Stocks09:19 EDT Precipio initiates second development project with H3 Biomedicine for gene panel - Precipio announced the initiation of a second development project with H3 Biomedicine that will include the creation of a targeted gene panel. The panel will include a pre-amplification multiplexed PCR that will amplify targeted regions of the key genes of interest. The panel would be used by H3 Biomedicine for their ongoing clinical development programs. The first project between H3 and Precipio was the development of multiplexed PCR assays for PIK3CA and ESR1 genes. The second development project between the companies will focus on the development of multiplexed PCR assays for FGFR3, PIK3CA, HRAS, TERT and PLEKHS1. During the project, Precipio will develop nine amplicons within the genes of interest and focus on the amplification and multiplexing of the mutations of interest.
|
PYDS | Hot Stocks09:10 EDT Payment Data Systems to change name to Usio - Payment Data Systems announced that the company has changed the name of the organization from Payment Data Systems to Usio. In conjunction with the name change, the company will also change its common stock ticker from (PYDS) to (USIO). The new symbol will be effective on July 1, when the company is scheduled to ring the Nasdaq closing bell.
|
AGN... | Hot Stocks09:07 EDT Fly Intel: Pre-market Movers - HIGHER: Allergan (AGN), up 31% after entering into a definitive transaction agreement under which AbbVie (ABBV) will acquire the company in a cash and stock transaction for an equity value of approximately $63B... Pyxus (PYX), up 15% after Imperial Capital analyst Mary Ross Gilbert initiated the stock with an Outperform rating and $71 price target, citing her view of the potential of the company to be a fast growing franchise for years given its combination of cultivation, extraction and e-liquids capabilities... ArQule (ARQL), up 3% after its 9.25M share spot secondary priced at $9.75 per share. UP AFTER EARNINGS: Lennar (LEN), up 4%. LOWER: AbbVie, down 10% after announcing its $63B cash and stock deal to acquire Allergan... Brighthouse Financial (BHF), down 9% after Credit Suisse analyst Andrew Kligerman downgraded shares to Underperform and Goldman Sachs analyst Alex Scott downgraded the stock to Sell... Pivotal Software (PVTL), down 3% after BofA/Merrill Lynch analyst Nikolay Beliov downgraded the stock to Underperform... Sally Beauty (SBH), down another 3% after yesterday's announcement of the launch of Amazon's (AMZN) professional beauty store... Aldeyra (ALDX), down 24% after reporting statistical significance was not achieved for endpoints in its SOLACE trial.
|
AETI | Hot Stocks09:05 EDT American Electric Tech. receives $725,000 distribution from Bomay joint venture - American Electric Tech. announced that it has received a distribution of $725,000 from its Chinese joint venture, Bomay, in which the company owns a 40% interest. The distribution resulted from the earnings of Bomay for the fiscal year ended December 31, 2018. Last year, Bomay received new orders for 40 control systems to be delivered for new Chinese domestic drilling rigs in 2019.
|
ACER | Hot Stocks09:00 EDT Acer Therapeutics Inc trading resumes
|
ABBV AGN | Hot Stocks08:50 EDT AbbVie says Allergan acquisition a 'transformative' transaction - Says: Allergan acquisition will have "profound impact" on AbbVie's growth story... Highly confident in Allergan's competitive position... Sees high single-digit growth for combined company over next decade... Deal is immediately accretive upon close... Cash flow significantly enhanced by merger... Transaction is financially compelling for all shareholders. Comments from AbbVie, Allergan acquisition conference call.
|
COUP AMZN | Hot Stocks08:46 EDT Coupa Software expands relationship with Amazon Web Services - Coupa Software announced an expanded relationship with Amazon (AMZN) Web Services, or AWS, to empower CIOs with more control over their IT spend. IT teams can now search, purchase, deploy, pay, and manage thousands of software products in AWS Marketplace using Coupa, giving them instant budget visibility and control in one place to spend smarter and simpler.
|
TDOC AXP | Hot Stocks08:43 EDT Teladoc names Mala Murthy CFO - Teladoc (TDOC) announced that it has named Mala Murthy as CFO. Joining most recently from American Express (AXP), Murthy brings a track record across a set of public companies and industries. Most recently, Murthy was CFO of the global commercial services segment of American Express, with responsibility for all aspects of financial management, including financial planning and analysis, M&A and investment and operating expense management.
|
TRWH | Hot Stocks08:40 EDT Twin River Worldwide announces $75M Dutch auction tender offer - Twin River Worldwide Holdings announced that it has commenced a modified "Dutch auction" tender offer to purchase shares of its common stock for cash at a price per share of not less than $29.50 nor greater than $33.00 in increments of 25c for a maximum aggregate purchase price of no more than $75M. The tender offer, which will be funded with cash on hand, begins today and will expire at 5:00 p.m., New York City time, on July 24 unless extended or earlier terminated by Twin River. When the tender offer expires, Twin River will determine the lowest price per share within the range specified above that will enable it to purchase the maximum number of shares of its common stock having an aggregate purchase price not exceeding $75M.
|
MBII | Hot Stocks08:39 EDT Marrone Bio receives notice of allowance from USPTO for Grandevo WDG patent - Marrone Bio has received a notice of allowance from the U.S. Patent and Trademark Office, or USPTO, for key claims covering the composition and method of manufacturing for Grandevo WDG, an MBI developed microbial-based bioinsecticide.
|
ACER | Hot Stocks08:37 EDT Acer Therapeutics receives complete response letter from FDA for Edsivo NDA - Acer Therapeutics announced it has received a complete response letter, or CRL, from the FDA regarding its new drug application, or NDA, for Edsivo for the treatment of vascular Ehlers-Danlos syndrome, or vEDS. The CRL states that it will be necessary to conduct an adequate and well-controlled trial to determine whether celiprolol reduces the risk of clinical events in patients with vEDS. Acer plans to request a meeting to discuss the FDA's response.
|
ANIP | Hot Stocks08:36 EDT ANI Pharmaceuticals launches Ranitidine Capsules - ANI Pharmaceuticals announced the launch of Ranitidine Capsules, 150mg and 300mg. The current annual U.S. market for this product is approximately $40M, according to Iqvia/IMS Health.
|
RCON | Hot Stocks08:35 EDT Recon Technology enters into sales representation agreement with Valvitalia - Recon Technology entered into an exclusive 24-month sales representation agreement with Valvitalia, a leading Italian producer of equipment for measuring, filtering, and regulating fluids, and gases serving customers in oil and natural gas, water, petrochemical, utilities markets worldwide, to promote Valvitalia products to China Petroleum Engineering & Construction Corporation. Pursuant to the terms of the Agreement, Valvitalia has granted Recon the exclusive right to sell Valvitalia products to CPECC, a Chinese subsidiary of China National Petroleum Corporation and specialized in oil engineering, manufacturing, construction and lump-sum contracting.
|
WING | Hot Stocks08:35 EDT Wingstop relocates corporate headquarters, acquires office building for $18.3M - Wingstop announced it will relocate its corporate headquarters to Addison, Texas, just north of Dallas, and has signed an agreement to acquire a 78,000 square foot office building for $18.3M. Completed in 2010, this thoughtfully designed facility offers an attractive layout with increased open areas, as well as designated space for innovation and kitchen testing to support the company's next phase of growth. The office is a three-story, modern corporate office building that will be occupied solely by Wingstop, allowing for increased flexibility and scalability as compared to the company's current multi-tenant building format. The design consists of a combination of open office areas, common spaces, conference rooms, training facilities and a fitness center. The new facility will also house the company's global test kitchen, innovation center and a mock Wingstop restaurant.
|
ITI | Hot Stocks08:35 EDT Iteris awarded 2-year contract by WYDOT - Iteris announced that it has been awarded a two-year contract by the Wyoming Department of Transportation, or WYDOT, continuing its support of the state's 511 service and maintaining its position as a market leader in the nationwide traveler information system market, with a 25% share.
|
PGNX | Hot Stocks08:33 EDT Velan Capital urges Progenics' stockholders to vote against re-election - Velan Capital, one of the largest stockholders of Progenics Pharmaceuticals, announced that it has issued a presentation to Progenics stockholders following various false and misleading statements made by the Company in its June 20th and June 24th presentations, urging stockholders to remain focused on the real issues facing the Company. The attempt by the Progenics Board of Directors to distort the truth and avoid accountability at all costs prove the Board's only defense is distraction and misdirection; the performance of the Company under the incumbent Board speaks for itself. The removal of Crowley and Kishbauch will implement much needed accountability and allow two new directors to more properly evaluate management and have a better chance of putting the Company on the right track. As long as such individuals bring appropriate alignment and expertise, we believe that stockholders and patients would be experiencing an upgrade. The Company's slogan is "Find, Fight, and Follow" - we urge stockholders to "Find" the status quo unacceptable, "Fight" years of value destruction and squandered opportunities, and "Follow" our call to action by voting AGAINST the re-election of Crowley and Kishbauch on the GREEN proxy card.
|
DOVA | Hot Stocks08:32 EDT Dova Pharmaceuticals granted marketing authorization for Doptelet - Dova Pharmaceuticals announced that the European Commission, or EC, has granted marketing authorization for Doptelet for the treatment of severe thrombocytopenia in adult patients with chronic liver disease, or CLD, who are scheduled to undergo an invasive procedure. Safety and efficacy data from two global Phase 3, double-blind, placebo-controlled trials, conducted in adults with thrombocytopenia and CLD, supported the EC marketing authorization. Doptelet was shown to be superior to placebo in increasing the proportion of patients not requiring platelet transfusions or rescue procedures for bleeding up to seven days following a scheduled procedure in both trials and both the 40 mg and 60 mg treatment groups. Doptelet was also superior to placebo at the two secondary efficacy endpoints in each trial. The marketing authorization applies to all 28 European Union member states plus Iceland, Norway, and Liechtenstein.
|
KNDI | Hot Stocks08:27 EDT Kandi Technologies joint venture receives $127.7M subsidy payment from China - Kandi Technologies announced that Kandi Electric Vehicles, a joint venture between Kandi and Geely Group has received a national subsidy payment of approximately $127.7M from the Chinese government for sales of new energy vehicles consisting of approximately $108.3M for pure energy vehicle sales during 2015 and 2016, and approximately$19.4M for partial EV sales in 2017.
|
ACER | Hot Stocks08:25 EDT Acer Therapeutics Inc trading halted, news pending
|
AMBS | Hot Stocks08:25 EDT Amarantus Bioscience to establish hemp-based JV with The Alchemist's Kitchen - Amarantus Bioscience announced that it has entered into a letter of intent, or LOI, with The Alchemist's Kitchen, a plant-based wellness company marketing the Plant Alchemy brand of health and wellness products, to establish a joint venture, or JV, for commercialization of hemp based herbal smokable products in addition to conducting research for cannabinoid derived addiction treatment, including smoking cessation and other indications such as insomnia. The initial equity ownership of Evolver Herbal Smokes will be 19.99% for Amarantus, and 80.01% for The Alchemist's Kitchen and/or its affiliates. Amarantus will have the right to acquire the remaining 80.01% equity of Evolver Herbal Smokes in conjunction with the listing of its common shares onto a national stock exchange. Under the terms of the agreement, The Alchemist's Kitchen's 'Plant Alchemy' brand, an ultra-premium brand of health & wellness products that include federally legal hemp derived cannabidiol, or CBD, products, will be the brand used for the products produced from the joint venture. The Alchemist's Kitchen is currently selling Plant Alchemy hemp-based smokable products out of their storefront in the Lower East Side in Manhattan, New York, and will contribute that currently selling Plant Alchemy smokable product line to the JV. Amarantus will contribute capital to the JV, will deploy its clinical development expertise and work closely with The Alchemist's Kitchen to conduct clinical research on the use of the Herbal Smokes.
|
IMMP | Hot Stocks08:16 EDT Immutep completes patient enrollment for AIPAC trial - Immutep announced that it has completed patient enrollment of the Phase 2b Active Immunotherapy PAClitaxel, or AIPAC, clinical trial in HER2-negative/ hormone receptor positive metastatic breast cancer, or MBC. The AIPAC study has enrolled 226 patients at more than 30 clinical trial sites across Germany, the UK, France, Hungary, Belgium, Poland and the Netherlands. The trial is evaluating Immutep's lead product candidate, eftilagimod alpha, in combination with paclitaxel, a standard of care chemotherapy, as a chemo-immunotherapy combination in patients with HR+ MBC not eligible for human epidermal receptor 2, or HER2, therapies. This combination is designed to boost the immune response against tumour cells compared to chemotherapy plus placebo. Apoptotic tumour cells induced by chemotherapy release antigenic tumour debris which are then captured by APCs. Boosting the APC network with efti increases cytotoxic T-cell responses which complements the direct cytotoxic effect of the chemotherapy. The primary endpoint of the AIPAC study is PFS according to RECIST as evaluated by blinded independent central readers. Additional efficacy endpoints include PFS by local read, overall response rate, or ORR, and overall survival. The company expects to report PFS data, together with ORR data, in Q1 of calendar year 2020.
|
BDRBF | Hot Stocks08:10 EDT Bombardier to sell Canadair regional jet program to MHI for $550M - Mitsubishi Heavy Industries, or MHI, and Bombardier announced they have entered into a definitive agreement, whereby MHI will acquire Bombardier's regional jet program for a cash consideration of $550M, payable to Bombardier upon closing, and the assumption by MHI of liabilities amounting to approximately $200M. Under the agreement, Bombardier's net beneficial interest in the Regional Aircraft Securitization Program, which is valued at approximately $180M, will be transferred to MHI. Pursuant to the agreement, MHI will acquire the maintenance, support, refurbishment, marketing and sales activities for the Canadair regional jet, or CRJ, Series aircraft, including the related services and support network located in Montreal, Quebec, and Toronto, Ontario, and its service centers located in Bridgeport, West Virginia, and Tucson, Arizona, as well as the type certificates. This acquisition is complementary to MHI's existing commercial aircraft business, in particular the development, production, sales and support of the Mitsubishi SpaceJet commercial aircraft family. The maintenance and engineering capabilities of the CRJ program will further enhance critical customer support functions, a strategic business area for MHI in the pursuit of future growth. The CRJ production facility in Mirabel, Quebec will remain with Bombardier. Bombardier will continue to supply components and spare parts and will assemble the current CRJ backlog on behalf of MHI. CRJ production is expected to conclude in the second half of 2020, following the delivery of the current backlog of aircraft. Bombardier will also retain certain liabilities representing a portion of the credit and residual value guarantees totaling approximately $400M. This amount is fixed and not subject to future changes in aircraft value, and payable by Bombardier over the next four years. The transaction is currently expected to close during the first half of 2020 and remains subject to regulatory approvals and customary closing conditions.
|
HUM | Hot Stocks08:08 EDT Humana enters collaboration with Aspen RxHealth - Aspen RxHealth announced that Humana has chosen the company's app-based platform to connect pharmacists with patients to deliver clinical services, including medication therapy management, or MTM. Aspen RxHealth will leverage their community of pharmacists to contact Humana Medicare Advantage members and review medications, provide education and answer questions about their therapy. Humana launched this program in Tampa, Florida, with a potential expansion into other markets later this year.
|
ACLS | Hot Stocks08:08 EDT Axcelis awarded first order for new Purion XE Power Series implanter - Axcelis Technologies announced that it has received the first order for the new Purion XE Power Series implanter from a leading power device manufacturer. The new Purion XE product line extension will be used in high volume production of power devices supporting automotive, mobile and the IoT market spaces. The system is scheduled to ship in the Q3. The Purion XE Power Series utilizes Axcelis' innovative solution for high temperature silicon carbide processing, which provides the capability to process 150mm SiC substrates to temperatures up to 700 degrees C.
|
PHG | Hot Stocks08:07 EDT Philips enters collaboration with BioBright - BioBright announced an agreement with Royal Philips to develop information solutions that improve the patient and clinician experience across the healthcare continuum. This development collaboration follows the participation of BioBright in the Philips HealthWorks Startup Program in Cambridge, MA.
|
VSAT TDY | Hot Stocks08:06 EDT ViaSat and Teledyne Controls announce partnership - Viasat (VSAT) and Teledyne Controls announced a partnership to bring real-time connected flight deck services to commercial airlines. Designed for Viasat in-flight connectivity customers, this partnership allows commercial airlines to decrease operational costs by eliminating expensive manual data off-loading processes; make better use of data mid-flight with improved data analysis and relevancy; and reduce data loss through preventative maintenance and the immediate access of flight deck information. Teledyne Controls is a wholly owned subsidiary of Teledyne Technologies (TDY).
|
HALO | Hot Stocks08:04 EDT Halozyme announces CRADA with VRC for use of ENHANZE technology - Halozyme Therapeutics announced a Cooperative Research and Development Agreement, or CRADA, with the National Institute of Allergy and Infectious Diseases' Vaccine Research Center, or VRC, part of the National Institutes of Health, enabling the VRC's use of Halozyme's ENHANZE drug delivery technology to develop subcutaneous formulations of broadly neutralizing antibodies, or bnAbs, against HIV for HIV treatment. The two bnAbs selected for the CRADA are VRC07-523LS and N6LS. The VRC will engage in early phase studies in healthy adults investigating the safety, tolerability, dose, and pharmacokinetics of formulating these bnAbs with ENHANZE(R) for the purpose of optimizing subcutaneous administration of these antibodies.
|
CBM CMD | Hot Stocks08:04 EDT Cambrex appoints Dottie Donnelly-Brienza CHRO - Cambrex (CBM) announced that Dottie Donnelly-Brienza has been appointed senior VP and CHRO. In this new role, she will have global responsibility for the company's human resources function and will join the company's executive management team. Brienza has over 20 years' HR experience in the life sciences sector, and joins Cambrex from Cantel Medical (CMD) where she was most recently CHRO.
|
ATNM | Hot Stocks08:02 EDT Actinium Pharma announces results from ACT program - Actinium Pharmaceuticals announced at SNMMI or the 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting that effective lymphodepletion with the radioisotope Lu-177 or lutetium-177 was achieved with its ACT or Adoptive Cell Therapy program for achieving safe, effective and transient lymphodepletion prior to the administration of CAR-T and other adoptive cell therapies. The ARC's or Antibody Radiation-Conjugates used in the ACT program combines a CD45 targeting antibody with the cell killing power of radioisotopes. Lymphodepletion is an important step prior to CAR-T and adoptive cell therapies that facilitates infused cells to engraft, expand and persist.
|
AKRX | Hot Stocks07:55 EDT Akorn trading resumes
|
JEC | Hot Stocks07:47 EDT Jacobs Engineering selected by Sepco for maritime project in Saudi Arabia - Jacobs has been selected by SEPCO Electric Power Construction to deliver engineering services for Packages 4, 5 and 6 of the King Salman International Complex for Maritime Industries and Services project at Ras Al Khair in the Kingdom of Saudi Arabia. The shipyard complex covers an area of 4.3 square kilometres and, when complete, will be the largest in the region, providing a combination of offshore structures fabrication, new ship building and maintenance, repair and overhaul services. The Jacobs team will deliver detailed design services to the project including piers, dry-docks, ship lift, buildings, supporting infrastructure, utilities, telecommunications and security systems.
|
PBTS | Hot Stocks07:45 EDT Powerbridge launches blockchain cross border compliance platform - Powerbridge announced the launch of Powerbridge blockchain cross border compliance platform at Nanning Customs, as part of the National Customs cross border technology innovation initiatives. Nanning Customs manages and regulates 26 cross border ports and marketplaces along China's southwestern border spanning 497 miles with neighboring Southeast Asian countries. Powerbridge blockchain cross border compliance platform is provided as blockchain-as-a-service to Nanning Customs starting with designated and limited use cases. The blockchain technology-enabled compliance applications and services are designed to allow the customs agency to increase the effectiveness of risk assessments and interventions in monitoring and controlling the flow of goods, documents and vendors for cross border trade events and transactions, with an enhanced level of regulatory information transparency and synchronization among customs agencies and other government authorities.
|
CAMP | Hot Stocks07:42 EDT CalAmp and Dogo Informatique announce partnership in Mexico - CalAmp and Dogo Informatique, a new CalAmp value-added distributor, announced a partnership to expand access to fleet and supply chain management solutions for fleet and asset managers, insurance providers and car rental companies across Mexico and Latin America. As major carriers move to shut down 2G networks across Mexico and Latin America, CalAmp and Dogo Informatique are teaming to deliver access to next-generation 3G and 4G networks providing higher speeds, increased reliability and more secure cellular connectivity.
|
AKRX | Hot Stocks07:38 EDT Akorn receives warning letter from FDA for New Jersey facility inspection - Akorn announced that it received a warning letter from the FDA related to the inspection of its Somerset, New Jersey manufacturing facility in July and August of 2018. Akorn is committed to quality and compliance, and will continue to work with the FDA to resolve all issues addressed in the warning letter. The company will respond to the FDA letter within the required 15 working days from receipt of the letter.
|
PCRX | Hot Stocks07:34 EDT Pacira announces EMA validation for Exparel MAA - Pacira announced that the company's marketing authorization application, or MAA, for Exparel for postsurgical analgesia was validated by the European Medicines Agency, or EMA. With this validation, the Pacira application is complete and the EMA Committee for Medicinal Products for Human Use will now begin the review procedure with an opinion expected in the second half of 2020. The MAA for Exparel is supported by clinical evidence across several surgical indications, including patients undergoing Cesarean section and total knee arthroplasty procedures.
|
BPMX | Hot Stocks07:31 EDT BioPharmX announces results from Phase 2b clinical trial of BPX-041 - BioPharmX announced positive results from its Phase 2b clinical trial of BPX-041, a novel topical gel formulation of fully solubilized minocycline for the treatment of moderate-to-severe papulopustular rosacea. BPX-04, a 1% minocycline gel, successfully met both the primary and secondary endpoints of the trial in demonstrating a statistically significant mean change in the number of facial inflammatory lesions and a two-grade improvement to clear or almost clear on the Investigator's Global Assessment, or IGA, scale from baseline to week 12.
|
AKRX | Hot Stocks07:30 EDT Akorn trading halted, news pending
|
ALDX | Hot Stocks07:30 EDT Aldeyra trading resumes
|
MYGN | Hot Stocks07:23 EDT Myriad Genetics announces publication of EndoPredict cost effectiveness study - Myriad Genetics announced that The Pharmacogenomics Journal published the results of the first cost-effectiveness analysis of the EndoPredict test compared to other breast cancer assays. The key finding is that EndoPredict test was more than twice as cost effective as Oncotype DX. This study examined the cost effectiveness of incorporating gene expression testing into standard practice using data from the Anastrozole or Tamoxifen Alone or Combined, or ATAC, clinical trial and cost data from the London Regional Cancer Program and other Canadian sources. The analysis evaluated three genetic tests compared to the clinicopathological features traditionally used to guide adjuvant treatment decisions. The primary endpoint was quality adjusted life years, which is a measure of the value of health outcomes. The results show that compared to the CP predictors alone-based strategy, EndoPredict was the single most cost-effective genetic test and was more than twice as cost effective as the market leading Oncotype DX test.
|
AVXL | Hot Stocks07:20 EDT Anavex announces first patient dosed in Rett syndrome extension study - Anavex announced that the first patient, who completed the Phase 2 clinical trial ANAVEX2-73-RS-001 voluntarily moved into the extension study and was dosed in the extension study for the treatment of Rett syndrome. The open label, 12 week extension study is designed to evaluate long term safety, tolerability and the effect of ANAVEX2-73 on Rett syndrome patients following the completion of the Phase 2 study.
|
AGTC... | Hot Stocks07:18 EDT Applied Genetic names Theresa Heah CMO, Brian Krex general counsel - Applied Genetic (AGTC) announced the appointment of Theresa Heah to the position of CMO. Heah will replace Matthew Feinsod, who will transition to a new role with responsibilities for developing and implementing global clinical and regulatory strategy, due diligence and licensing. AGTC also announced the appointment of Brian Krex as general counsel, who will oversee the company's legal function. Heah brings more than ten years of senior executive pharmaceutical experience to her new role, with previous responsibilities ranging from drug development to successful product commercialization. Most recently, Heah was VP of clinical research, medical and professional affairs at Aerie Pharmaceuticals (AERI) and had responsibility as global head for clinical research, medical affairs and professional affairs, and advancing the company's pipeline of product candidates to approval and launch. Heah will join AGTC on July 29. Prior to joining AGTC, Brian Krex was VP and global head of commercial and regulatory law with Alexion (ALXN).
|
ARVN | Hot Stocks07:12 EDT Arvinas announces FDA clearance of ARV-471 IND - Arvinas announced that the FDA has cleared the company's investigational new drug application, or IND, for ARV-471, an oral estrogen receptor, or ER, Protac protein degrader, designed to selectively target ER for the treatment of patients with locally advanced or metastatic ER positive / HER2 negative breast cancer. Arvinas expects to initiate a Phase 1 clinical trial for ARV-471 in Q3. ARV-471 is a Protac protein degrader specifically designed to target and degrade ER. The Phase 1 trial will assess the safety, tolerability and pharmacokinetics of ARV-471, and will also include measures of anti-tumor activity and pharmacodynamic readouts as secondary endpoints.
|
FDS | Hot Stocks07:10 EDT FactSet increases share repurchase program by $210M - The board of directors of FactSet approved an increase of $210M to the existing share repurchase program. Including this increase, $300M is currently available for share repurchases.
|
NTEC | Hot Stocks07:05 EDT Intec Pharma publishes results from Phase 2 clinical study of AP-CD/LD - Intec Pharma announces that results from an earlier Phase 2 clinical study of the Accordion Pill-Carbidopa/Levodopa, or AP-CD/LD, in Parkinson's disease, or PD, patients were published in the peer-reviewed journal, Parkinsonism and Related Disorders. The article titled, "Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa in Parkinson's disease" is now available online as an e-publication ahead of print. The article reviews pharmacokinetic and efficacy data from the Company's phase 2, multicenter, open-label, two-way randomized crossover study that evaluated multiple dose strengths of the AP-CD/LD twice daily in one treatment period and an active comparator in the other treatment period. The PK results showed that compared with IR-CD/LD, treatment with either AP-CD/LD dose demonstrated more stable LD plasma concentrations in both fluctuating and non-fluctuating PD patients, and significantly decreased the LD Cmax.
|
ALDX | Hot Stocks07:05 EDT Aldeyra says statistical significance not achieved for endpoints in SOLACE Trial - Aldeyra Therapeutics announced results from the noninfectious anterior uveitis SOLACE Trial. Statistical significance was not achieved for the primary or secondary endpoints, due to high rates of disease resolution in vehicle-treated patients, but activity of reproxalap was consistently greater than that of vehicle. "The results of the SOLACE Trial confirm the potential of reproxalap to treat ocular inflammation, and further validate the novel mechanism of action of reproxalap, which demonstrated highly statistically significant immune-modulating activity in the Phase 3 ALLEVIATE Trial and Phase 2b Dry Eye Disease trial," stated Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra. "We look forward to aggressively prioritizing advancement of high-value ocular programs in dry eye disease, allergic conjunctivitis, and proliferative vitreoretinopathy." Topical ocular reproxalap was observed to be safe and well-tolerated. Reproxalap ophthalmic solution, in various concentrations, has now been administered to over 800 patients in nine clinical trials for ocular inflammation.
|
ALDX | Hot Stocks07:04 EDT Aldeyra says statistical significance not achieved for endpoints in SOLACE Trial
|
NVRO... | Hot Stocks07:03 EDT Nevro announces appointment of two senior executives to leadership team - Nevro (NVRO) announced the appointments of two senior executives to the Company's leadership team. Niamh Pellegrini has been named Chief Commercial Officer, responsible for all global sales and marketing-related activities, and Lori Ciano has been named Chief Human Resources Officer. Pellegrini and Ciano will report directly to D. Keith Grossman, Chairman, CEO and President. Niamh Pellegrini is a proven commercial leader with 20 years of experience in the healthcare industry. Prior to joining Nevro, Pellegrini was Vice President of Global Commercial Operations for Abbott (ABBT) Vascular, where she was responsible for driving approximately $3B in revenue. Prior to Abbott, Pellegrini served as CEO and President at Autonomic Technologies, where she led a turnaround of its European commercial business and drove U.S. market access. Lori Ciano brings more than 15 years of experience as a senior human resources leader in both the life sciences and technology industries. Prior to joining Nevro, Ciano was Senior Vice President, Human Resources at Dermira (DERM), a Menlo Park-based biotechnology company. Prior to Dermira, Lori served as Vice President of Information Technology and Chief Human Resources Officer at Thoratec leading up to the company's acquisition.
|
CUB IBM | Hot Stocks07:03 EDT Cubic names Jim Colson as VP, Chief Technology Officer - Cubic (CUB) announced the appointment of Jim Colson as vice president and chief technology officer. Colson will join Cubic's executive team to define and drive transformative platforms, including cloud and mobile across all Cubic business divisions. Colson retired from IBM (IBM) as an IBM Fellow, vice president and worldwide CTO for the AI and ML infused Watson Customer Engagement portfolio.
|
V RMBS | Hot Stocks07:03 EDT Visa to acquire Rambus payments portfolio - Visa (V) announced it has signed a definitive agreement to acquire the token services and ticketing businesses, formerly Bell ID and Ecebs LTD, from Rambus (RMBS). "The combination of Visa's network tokenization capabilities with the local and account tokenization technology of Rambus will facilitate safer, more secure payments across all forms of global commerce." The transaction is subject to relevant regulatory approvals and other customary closing conditions.
|
BHC | Hot Stocks07:02 EDT Bausch Health announces U.S. launch of DUOBRII Lotion - Bausch Health Companies and its dermatology business, Ortho Dermatologics, announced that DUOBRII Lotion, 0.01%/0.045%, will be available commercially to health care professionals starting this week. Approved by the U.S. FDA on April 25, DUOBRII is the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation.
|
ALDX | Hot Stocks06:56 EDT Aldeyra trading halted, news pending
|
CTVA | Hot Stocks06:55 EDT Corteva recommends shareholders reject mini-tender offer by TRC Capital - Corteva has been notified of an unsolicited mini-tender offer by TRC Capital, or TRC, to purchase up to 5M shares, or approximately 0.67%, of the outstanding common stock of Corteva at a price of $26.00 per share in cash. TRC's offer price is approximately 4.45% less than the $27.21 closing price of Corteva's common stock on June 21, the day before the mini-tender offer commenced, and is approximately 7.18% less than the $28.01 closing price of Corteva's common stock on June 24. Corteva does not endorse TRC's mini-tender offer and recommends that Corteva stockholders do not tender their shares in response to the offer because it is a mini-tender offer at a price below the market price for Corteva shares and is subject to numerous conditions. According to TRC's offer documents, Corteva stockholders who have already tendered their shares may withdraw their shares at any time prior to July 24, the expiration date set forth in the offer documents, by following the procedures described in the offer documents. Corteva urges stockholders to obtain current market quotes for their shares, to review the conditions to TRC's mini-tender offer, to consult with their brokers or financial advisors and to exercise caution with respect to this mini-tender offer. Corteva is not associated with TRC, its mini-tender offer or the offer documentation. TRC has made similar mini-tender offers for shares of other companies.
|
ABBV AGN | Hot Stocks06:50 EDT AbbVie to acquire Allergan in cash, stock deal valued around $63B - AbbVie (ABBV) and Allergan (AGN) announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63B, based on the closing price of AbbVie's common stock of $78.45 on June 24. Upon completion of the transaction, AbbVie will continue to be incorporated in Delaware as AbbVie Inc. and have its principal executive offices in North Chicago, IL. AbbVie will continue to be led by Richard Gonzalez as chairman and CEO. Two members of Allergan's board, including chairman and CEO, Brent Saunders, will join AbbVie's board upon completion of the transaction. Under the terms of the Transaction Agreement, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan Share that they hold, for a total consideration of $188.24 per Allergan Share. The transaction represents a 45% premium to the closing price of Allergan's Shares on June 24. AbbVie anticipates that the Acquisition will provide annual pre-tax synergies and other cost reductions of at least $2B in year three while leaving investments in key growth franchises untouched. The synergies and other cost reductions will be a result of optimizing the research and early stage portfolio, and reducing overlapping R&D resources, driving efficiencies in SG&A, including sales and marketing and central support function costs, and eliminating redundancies in manufacturing and supply chain, and leveraging procurement spend. The synergies estimate excludes any potential revenue synergies. AbbVie is expected to generate significant annual operating cash flow, which will support a debt reduction target of $15B to $18B before the end of 2021, while also enabling a continued commitment to Baa2/BBB or better credit rating and continued dividend growth. It is expected that, immediately after the closing of the Acquisition, AbbVie Shareholders will own approximately 83% of AbbVie on a fully diluted basis and the Allergan Shareholders will own approximately 17% of AbbVie on a fully diluted basis.
|
ABBV AGN | Hot Stocks06:45 EDT AbbVie to acquire Allergan in cash, stock deal valued around $63B
|
CODX | Hot Stocks06:33 EDT Co-Diagnostics launches Logix Smart ZDC multiplex test - Co-Diagnostics announced the launch of their Logix Smart ZDC multiplex test at the 64th Annual 2019 Caribbean Public Health Agency, or CARPHA, Health Research Conference. The ZDC multiplex test was designed to detect the presence of Zika, dengue, and chikungunya within a single polymerase chain reaction test.
|
BW | Hot Stocks06:32 EDT Babcock & Wilcox sells Loibl to subsidiary of Deutsche Invest Mittelstand - Babcock & Wilcox Enterprises announced that it has sold its Straubing, Bavaria, Germany-based material handling subsidiary, Babcock & Wilcox Loibl, to a subsidiary of Deutsche Invest Mittelstand. "The proceeds from B&W's sale of Loibl will be used to reduce debt, provide working capital and strengthen the company's liquidity and overall financial position, as well as help us focus on our core businesses," said the company. ACXIT Capital Partners, headquartered in Frankfurt, Germany, served as B&W's M&A advisor on the transaction.
|
CR CIR | Hot Stocks06:32 EDT Crane refutes Circor's plan, urges shareholders to tender shares - Crane (CR) filed a detailed response to CIRCOR International's (CIR) revised business plan. Crane Co.'s analysis underscores its belief that CIRCOR's claims are highly unrealistic and illustrates why its superior, all-cash offer of $45 per share represents the best option for CIRCOR shareholders. Max Mitchell, Crane Co. President and CEO commented, "CIRCOR's short-term plan, while expected, is yet another set of empty promises. This, coupled with CIRCOR's track record of repeatedly missing its own targets, significant underperformance, and value destruction, make it extremely clear that Crane Co.'s $45 per share offer represents the superior option, with certain and attractive value." He continued, "CIRCOR shareholders have both publicly and privately expressed their frustration with CIRCOR's ability to drive value for them. We urge them to tender their shares to encourage CIRCOR's Board to engage with us in good faith negotiation." Crane Co. remains confident that the certainty of its fully financed, all-cash offer at a significant premium is the best outcome for CIRCOR shareholders. Crane Co. urges CIRCOR shareholders to tender their shares into the tender offer.
|
PT | Hot Stocks06:27 EDT Pintec Technology announces strategic partnership with Bank of Ganzhou - Pintec Technology inked a strategic partnership agreement with Bank of Ganzhou in Jiangxi Province for cooperation in financial innovation and services, including fintech research and development, intelligent asset allocation and e-commerce. According to the partnership agreement, Pintec and Bank of Ganzhou will jointly establish a fintech research and development center, focusing on advanced fintech researches in big data, cloud computing, artificial intelligence, financial security and block chain. Pintec will also support Bank of Ganzhou in developing a digital operation system with data services covering all business scenarios and procedures, and launching new products and services for finance. Bank of Ganzhou is a state-owned regional commercial bank supervised by the Ganzhou government. With its advanced financial technology and experience, Pintec will provide Bank of Ganzhou with efficient and customized lending solutions for individual financing, small and micro-sized enterprises financing and industry chain financing.
|
RDY | Hot Stocks06:24 EDT Dr. Reddy's launches its Tobramycin Inhalation Solution - Dr. Reddy's Laboratories along with its subsidiaries, announced the launch of Tobramycin Inhalation Solution, USP a therapeutic equivalent generic version of TOBI, or tobramycin, Inhalation Solution, approved by the FDA. The TOBI Inhalation Solution brand and generic had U.S. sales of approximately $97M MAT for the most recent twelve months ending in April 2019 according to IQVIA Health.
|
IMRN | Hot Stocks06:05 EDT Immuron Directors increase shareholdings in the company - Immuron wishes to advise that two of its Directors, Peter Anastasiou and Daniel Pollock have recently acquired on-market 1M (25,000 ADS equivalent) and 145,000 (3,625 ADS equivalent) IMC fully paid ordinary shares respectively since May. The recent acquisitions made by Peter Anastasiou and related entities take his effective ownership in the company to 10.93% in voting power representing 17,836,144 IMC fully paid ordinary shares (445,904 ADS equivalent).
|
USWS | Hot Stocks06:05 EDT U.S. Well Services signs agreement with AmeriMex Motor & Controls - U.S. Well Services announced that it has entered into an agreement with AmeriMex Motor & Controls, a subsidiary of Industrial Service Solutions. Under the terms of the agreement, AmeriMex will provide electric motors exclusively to USWS as it relates to electric hydraulic fracturing. USWS and AmeriMex jointly developed an electric motor tailored for hydraulic fracturing applications utilizing insights gained from data collected by USWS's FracMD technology and the Company's five year operating history with electric fracturing fleets. U.S. Well Services has utilized these world-class, fit-for-purpose motors on each of its three newbuild electric fracturing fleets deployed in 2019, and is currently constructing a fourth newbuild electric fleet using the motors, which is contracted and expected to begin working for a supermajor in the Permian Basin in early 2020.
|
AMCR | Hot Stocks06:03 EDT Amcor enters into $394M agreement for sale of three flexible packaging plants - Amcor announces it has entered into a binding agreement with Kohlberg & Company, for the sale of three former Bemis plants located in the United Kingdom and Ireland for cash consideration of $394M. Collectively these three plants generate annual sales of approximately $170M from the sale of flexible packaging for certain healthcare products. This divestment was required by the European Commission at the time of approving Amcor's acquisition of Bemis on February 11. The sale remains subject to customary approvals including European Commission approval of Kohlberg & Company as the buyer and is expected to close in the coming weeks.
|
EQT | Hot Stocks06:03 EDT Rice Team urges EQT Corporation shareholders to vote for Rice Team nominees - The Rice Team, shareholders of EQT Corporation, released a letter from John McCartney, a Rice Team nominee for the EQT Board of Directors, to fellow EQT shareholders. In the letter, McCartney, who is an EQT shareholder and has served as a director on nine public company boards, including on the Rice Energy board from March 2015 through its merger with EQT in November 2017, notes the Rice Team's intensely analytical, data and technology-driven decision processes as being central to Rice Energy's success. He also highlights the Rice Team's ability to fuse technology and human capital to generate remarkable results - Rice Energy had the lowest well development costs in the Appalachian Basin, the highest average well productivity and was recognized as an energizing and empowering place to work - in turn creating tremendous value for shareholders. In particular, McCartney credits Toby Rice's visionary ability to apply a new, technology-enabled approach to the company's complex tasks of land acquisition, well design, well construction, upstream and midstream coordination, and other critical operations. He said, "I believe the Rice Team nominees, and Toby Rice as a CEO, can make that happen. Please vote for all of the Rice Team nominees."
|
PLL | Hot Stocks06:03 EDT Piedmont Lithium announces 47% increase in Piedmont mineral resource estimate - Piedmont Lithium announced a major update to the Mineral Resource estimate for the Company's wholly-owned Piedmont Lithium Project located within the world-class Carolina Tin-Spodumene Belt, or TSB, in North Carolina, USA. The Mineral Resource for the Core property has increased to 25.1M tonnes, or Mt, at a grade of 1.09% Li2O, bringing the Project's total Mineral Resources to 27.9 Mt at a grade of 1.11% Li2O, containing 309,000 tonnes of lithium oxide, or Li2O, or 764,000 tonnes of lithium carbonate equivalent, or LCE, Importantly, 74% of the Core Mineral Resource is within 100m of surface and 97% is within 150m of surface. Approximately 50%; or 12.5Mt of the Mineral Resource is classified in the Indicated Resource category. All of the Mineral Resource tonnes at both Core and Central properties are attributable to spodumene mineralization.
|
CTRP | Hot Stocks06:00 EDT Ctrip enters strategic partnership with Tourism Fiji - Ctrip has signed a memorandum of understanding, or MOU, with Tourism Fiji and Fiji Airways at the Ctrip Headquarter in Shanghai. This MOU will enable Ctrip to work closely with Tourism Fiji and Fiji Airways on business development and joint promotional activities. This will help to accelerate Fiji's existing marketing activities in China.
|
XONE SIEGY | Hot Stocks05:28 EDT ExOne announces partnership with Siemens - ExOne (XONE) announced a partnership with Siemens (SIEGY) "that will benefit industrial customers in the foundry, aerospace, automotive, energy and other markets." Siemens' Digital Enterprise Portfolio of software and automation technology including MindSphere are fully implemented on the all-new S-Max Pro sand printer, that can achieve print speeds of up to 135 l/h.
|
DERM | Hot Stocks05:23 EDT Almirall exercises option with Dermira to license rights to lebrikizumab in EU - Almirall and Dermira announced that Almirall has exercised its option to license rights to develop and commercialize lebrikizumab for the treatment of atopic dermatitis and certain other indications in Europe. Almirall and Dermira previously entered into an option and license agreement in February pursuant to which Almirall was granted this exclusive option in exchange for an upfront option fee of $30M. As a result of Almirall's decision to exercise its option, the company will pay Dermira $50M, and Dermira will be eligible to receive additional payments upon the achievement of certain milestones, including $30 million in connection with the initiation of certain Phase 3 clinical studies. Under the terms of the option and license agreement entered into between Almirall and Dermira in February, Almirall paid Dermira an upfront option fee of $30 million in exchange for an option to acquire an exclusive license to develop lebrikizumab in dermatology indications and commercialize lebrikizumab in all indications in Europe. As a result of its decision to exercise its option, Almirall will pay Dermira an option exercise fee of $50M. In addition, Almirall will make additional payments to Dermira upon the achievement of certain milestones, including $30M in connection with the initiation of certain Phase 3 clinical studies and up to $85M upon the achievement of regulatory milestones and the first commercial sale of lebrikizumab in Europe. Dermira will also be entitled to receive milestone payments upon the achievement of certain thresholds for net sales of lebrikizumab in Europe, as well as royalty payments representing percentages of net sales that range from the low double-digits to the low twenties.
|
AMZN | Hot Stocks05:13 EDT Amazon announces 48 hour Prime Day July 15 & 16 - Amazon said, "This July, Amazon will provide Prime members worldwide the chance to get epic deals during its longest Prime Day ever. Prime Day starts at midnight PT on Monday, July 15 and - for the first time ever - runs for 48 hours, offering members two full days with more than one million deals around the world. Prime Day will be the biggest celebration of deals with limited-time offers, never-before-seen entertainment and exclusive launches online and in-store. Also, members will find the biggest Prime Day deals ever on Alexa-enabled devices. And one of the best Prime Day deals starts today - save $120 on Toshiba HD 43-inch Fire TV Edition Smart TV, only $179.99, through June 30 or while supplies last. Prime members in the U.S., U.K., Spain, Singapore, Netherlands, Mexico, Luxembourg, Japan, Italy, India, Germany, France, China, Canada, Belgium, Austria, Australia and - new this year - United Arab Emirates, can shop our best day(s) of deals. Not a Prime member yet? Anyone can join Prime or start a 30-day free trial at amazon.com/primeday to participate in Prime Day."
|